Clinical Development Pipeline
Program Indications |
|
Worldwide rights |
|||||
KINETIC COVID-19 hospitalized patients (severe) |
|
![]() |
|||||
KINFAST COVID-19 ambulatory patients (mild-to-moderate) |
|
![]() |
|||||
KIN001-AMD Wet-AMD patients (maintenance of vision) |
|
![]() |
|||||
KIN001-IPF Idiopathic Pulmonary Fibrosis (rare lung disease) |
|
![]() |